Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

First Reported Use of the Faxitron LOCalizer™ Radiofrequency Identification (RFID) System in Europe - A Feasibility Trial, Surgical Guide and Review for Non-palpable Breast Lesions.

Malter W, Holtschmidt J, Thangarajah F, Mallmann P, Krug B, Warm M, Eichler C.

In Vivo. 2019 Sep-Oct;33(5):1559-1564. doi: 10.21873/invivo.11637.

2.

Reply to E. Hindié and A.K. Goel et al.

Holtschmidt J, Kuemmel S, Krug D, Breit E, Kuehn T, Reinisch M.

J Clin Oncol. 2019 Oct 10;37(29):2705-2707. doi: 10.1200/JCO.19.01860. Epub 2019 Aug 29. No abstract available.

PMID:
31465263
3.

Autologous Lipotransfer - Daily Therapeutic Practice in Breast Cancer: An Intergroup Analysis Encompassing NOGGO, WSG, GBG, AWO Gyn and DGPRÄC.

Kümmel A, Kümmel S, Blohmer JU, Faridi A, Nitz U, Loibl S, von Fritschen U, Rezek D, Hagemann F, Holtschmidt J, Botzenhardt S, Reinisch M.

Breast Care (Basel). 2019 Jun;14(3):165-169. doi: 10.1159/000490040. Epub 2018 Nov 14.

PMID:
31316315
4.

Prospective, Multicenter, Randomized Phase III Trial Evaluating the Impact of Lymphoscintigraphy as Part of Sentinel Node Biopsy in Early Breast Cancer: SenSzi (GBG80) Trial.

Kuemmel S, Holtschmidt J, Gerber B, Von der Assen A, Heil J, Thill M, Krug D, Schem C, Denkert C, Lubitz J, Blohmer JU, Reinisch M, Hötzeldt M, Seither F, Nekljudova V, Schwidde I, Uhrhan K, Von Minckwitz G, Rezai M, Mulowski J, Loibl S, Kuehn T.

J Clin Oncol. 2019 Jun 10;37(17):1490-1498. doi: 10.1200/JCO.18.02092. Epub 2019 May 1.

PMID:
31042410
5.

Profile and Outcome of Supraclavicular Metastases in Patients with Metastatic Breast Cancer: Discordance of Receptor Status Between Primary and Metastatic Site.

Thangarajah F, Vogel C, Pahmeyer C, Eichler C, Holtschmidt J, Ratiu D, Mallmann P, Malter W.

Anticancer Res. 2018 Oct;38(10):6023-6026. doi: 10.21873/anticanres.12952.

PMID:
30275235
6.

Using a New Marker Clip System in Breast Cancer: Tumark Vision® Clip - Feasibility Testing in Everyday Clinical Practice.

Rüland AM, Hagemann F, Reinisch M, Holtschmidt J, Kümmel A, Dittmer-Grabowski C, Stöblen F, Rotthaus H, Dreesmann V, Blohmer JU, Kümmel S.

Breast Care (Basel). 2018 Apr;13(2):116-120. doi: 10.1159/000486388. Epub 2018 Mar 9.

7.

Prognostic Factors for Local, Loco-regional and Systemic Recurrence in Early-stage Breast Cancer.

Kümmel A, Kümmel S, Barinoff J, Heitz F, Holtschmidt J, Weikel W, Lorenz-Salehi F, du Bois A, Harter P, Traut A, Blohmer JU, Ataseven B.

Geburtshilfe Frauenheilkd. 2015 Jul;75(7):710-718.

8.

Additional prognostic value of lymph node ratio over pN staging in different breast cancer subtypes based on the results of 1,656 patients.

Ataseven B, Kümmel S, Weikel W, Heitz F, Holtschmidt J, Lorenz-Salehi F, Kümmel A, Traut A, Blohmer J, Harter P, du Bois A.

Arch Gynecol Obstet. 2015 May;291(5):1153-66. doi: 10.1007/s00404-014-3528-6. Epub 2014 Nov 5.

PMID:
25367604
9.

Hematogenous dissemination of glioblastoma multiforme.

Müller C, Holtschmidt J, Auer M, Heitzer E, Lamszus K, Schulte A, Matschke J, Langer-Freitag S, Gasch C, Stoupiec M, Mauermann O, Peine S, Glatzel M, Speicher MR, Geigl JB, Westphal M, Pantel K, Riethdorf S.

Sci Transl Med. 2014 Jul 30;6(247):247ra101. doi: 10.1126/scitranslmed.3009095.

10.

Surgical treatment of primary breast cancer in the neoadjuvant setting.

Kümmel S, Holtschmidt J, Loibl S.

Br J Surg. 2014 Jul;101(8):912-24. doi: 10.1002/bjs.9545. Epub 2014 May 19. Review.

PMID:
24838656
11.

Sympathicus-Heterochromie und Hemiatrophia faciei progressiva.

HOLTSCHMIDT J.

Hautarzt. 1954 Jun;5(6):255-7. German. No abstract available.

PMID:
13200950
12.

[Treatment of scleroderma].

HOLTSCHMIDT J.

Dtsch Med Wochenschr. 1953 Jun 5;78(23):853-4. Undetermined Language. No abstract available.

PMID:
13068009
13.

[Relations of the Klippel-Trénaunay-Weber syndrome to the partial gigantism].

FEGELER F, HOLTSCHMIDT J, KOHRS S.

Arch Dermatol Syph. 1953;195(4):402-33. Undetermined Language. No abstract available.

PMID:
13066041
14.

[Therapy of lupus erythematodes with penicillin and fever].

HOLTSCHMIDT J.

Hautarzt. 1952 Oct;3(10):465-6. Undetermined Language. No abstract available.

PMID:
13010651
15.

[Apathogenic blood and skin spirochaetae].

GOHLKE H, HOLTSCHMIDT J.

Hautarzt. 1952 Oct;3(10):450-3. Undetermined Language. No abstract available.

PMID:
13010644
16.

[Sun baths causing lupus erythematosus in sanitorium therapy of pulmonary tuberculosis].

JORDAN P, HOLTSCHMIDT J.

Tuberkulosearzt. 1952 Oct;6(10):601-4. Undetermined Language. No abstract available.

PMID:
13005755
17.

[Sclerodermiform basaliomata].

HERZBERG JJ, HOLTSCHMIDT J.

Hautarzt. 1952 Aug;3(8):371-2. Undetermined Language. No abstract available.

PMID:
12989743
18.

[Etiology and therapy of strophulus].

WULF K, HOLTSCHMIDT J.

Hautarzt. 1952 Jun;3(6):267-70. Undetermined Language. No abstract available.

PMID:
12980463
19.

[Igelite dermatitis].

HOLTSCHMIDT J.

Hautarzt. 1952 May;3(5):227-8. Undetermined Language. No abstract available.

PMID:
14945745
20.

[Pathogen resistance to, and therapy of bacterial skin diseases with pyosanvasogen].

MEINICKE K, HOLTSCHMIDT J.

Munch Med Wochenschr. 1952 Feb 22;94(8):361-3. Undetermined Language. No abstract available.

PMID:
14919482

Supplemental Content

Loading ...
Support Center